City of Bothell Mayor Joshua Freed joined Gov. Jay Inslee, Seattle Mayor Ed Murray, and other state and local leaders on March 16 at a press conference hosted by Juno Therapeutics. Juno’s CEO Hans Bishop announced its commitment to base operations in Washington State and to locate its manufacturing operation in Bothell.

“The city of Bothell is extremely pleased to welcome Juno Therapeutics to our workforce,” Freed said. “The city continues to build its reputation as a center in the biomedical, high tech field, and we wish Juno Therapeutics every success with their clinical trials.”

Juno Therapeutics, a start-up biotechnology company with headquarters in Seattle, signed a lease agreement for a manufacturing facility in Bothell, where the company will make its immunotherapy cancer treatment. The company leased an existing 68,000 square foot building on the Bothell-Everett Highway that was redeveloped in 2008 for biotech tenants. Juno’s initial use of the site will be for small-lot manufacturing, increasing their ability to produce product for multiple clinical trials and commercialize their pipeline of additional products. They expect to open the new facility in early 2016. Prior to their IPO in December 2014, the company had accumulated $314 million in capital.